Name: Directed Induction of Retinal Organoids from Human Pluripotent Stem Cells (Video) | JoVE Journal
Uploaded: 2021-04-21T13:30:00.000+00:00
Duration: 6 min 38 s
Description: Learn to generate retinal organoids from human pluripotent stem cells using feeder-free culture and manual selection. This optimized protocol enhances photoreceptor precursor yield for disease modeling and transplantation research.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

We thank members of 502 laboratory for their technical supports and helpful comments regarding the manuscript. This work was partly supported by the Beijing Municipal Natural Science Foundation (Z200014) and National Key R&#38;D Program of China (2017YFA0105300).

This study was approved by the institutional Ethics Committee of Beijing Tongren Hospital, Capital Medical University. H9 hESCs were obtained from the WiCell Research Institute and genetically engineered to tdTomato-tagged cell line.
1. Generation of human ROs
<ol>
	<li>Culture the hESCs under feeder-free conditions.
	<ol>
		<li>Coat one well of a 6-well plate with 1 mL of 0.1 mg/mL reagent A (Table of Materials) at 37 &#176;C for at least half an hour following the manufacturer&#39;s instructions. Thaw an aliquot of 1x106 hESCs. 
		NOTE: Prepare 3 mL of pre-warmed reagent B (Table of Materials) and transfer the cryopreserved cells (1 mL) into 3 mL of fresh medium. Do not pipette the hESCs to single cells.</li>
		<li>Centrifuge at 200 x g for 5 min and remove the supernatant.</li>
		<li>Seed the cells into the reagent A-coated plate with 2 mL of reagent B and change 2 mL of reagent B daily. Passage cells when reaching approximately 80% confluency (usually around 4 days).</li>
	</ol>
	</li>
	<li>Day 0
	<ol>
		<li>Dissociate hESCs to a single-cell suspension using medium I (Table 1). Prepare medium I by mixing the following: 20% (v/v) KnockOut serum replacement (KSR), 0.1 mM MEM non-essential amino acids solution (NEAA), 1 mM pyruvate,3 &#181;M IWR-1-endo (IWR1e), 30 ng/mL COCO, 100 U/mL penicillin, 100 &#181;g/mL streptomycin (PS), 0.1 mM &#946;-mercaptoethanol, and Glasgow&#39;s Eagle&#39;s minimal essential medium (GMEM). 
		NOTE: Before the start of the dissociation, prepare medium I and transfer 12 mL of medium I with 20 &#181;M Y-27632 into a 10 cm Petri dish, 500 &#181;L of reagent C (Table of Materials) containing 0.05 mg/mL of reagent D (Table of Materials) and 20 &#181;M Y-27632 in a 1.5 mL tube. Perform the above steps in the dark, as component IWR1e in medium I is light-sensitive.</li>
		<li>Wash the hESCs with pre-warmed 1x Dulbecco&#39;s phosphate-buffered saline (DPBS) buffer.</li>
		<li>Add the prepared 500 &#181;L reagent (in the 1.5 mL) tube and incubate the hESCs for 3.5 min at 37 &#176;C and 5% CO2.</li>
		<li>Detach the cells by flicking the side and bottom of the plate for a few seconds and add 500 &#181;L of prepared medium I from the Petri dish into the hESC plate. 
		NOTE: Prepare a 1.5 mL tube with 900 &#181;L of 1x DPBS and use a hemocytometer for cell counting.</li>
		<li>Harvest the cells in a new 1.5 mL tube and pipette the cell suspension up and down and then take out 100 &#181;L from the tube and then add into the tube with 900 &#181;L of DPBS for cell counting.</li>
		<li>Disperse the left 900 &#181;L cell suspension and then dilute the cells with prepared medium I in the Petri dish to 9 x 104 cells/mL. 
		NOTE: The whole volume of the medium is 12 mL; 1.08 x 106 cells are needed in total.</li>
		<li>Add 100 &#181;L of cell suspension to each well of a non-adherent, V-bottom, 96-well plate (Table of Materials). 
		NOTE: Use a multichannel pipette to shorten the time and ensure that each well contains an equivalent cell number. Shake the Petri dish each time before removing 100 &#181;L portions. It is important that the cells are uniformly distributed.</li>
		<li>Lightly spin down the 96-well plate in a low-speed shaker for 5 min and then incubate at 37 &#176;C and 5% CO2. 
		NOTE: Keep the plate in dark. Set the day as day 0.</li>
	</ol>
	</li>
	<li>Day 2
	<ol>
		<li>Add 1% reagent A (Table of Materials). Prepare reagent A (protein concentration of 10 mg/mL) by adding 133.4 &#181;L of reagent A into 2 mL of medium I. 
		NOTE: Maintain reagent A at 4 &#176;C overnight before use to achieve complete and uniform melting. Please note the product information and search the catalog number the and the lot number in the official website of the company to have the protein concentration of reagent A as each bottle of reagent A is at a different protein concentration. If the protein concentration is low, an increased volume of reagent A would be helpful.</li>
		<li>Add 20 &#181;L of prepared reagent A to each well and pipette twice in the center to scatter the dead cells. 
		NOTE: Maintain the reagent A and the 96-well plate under cool conditions and complete all the steps on ice. Place the plate in dark.</li>
	</ol>
	</li>
	<li>Day 2-12
	<ol>
		<li>Clean the bottom of the 96-well plate and incubate at 37 &#176;C and 5% CO2 until day 6. At day 6, change half of the medium by removing 58 &#181;L of the medium from each well and adding 60 &#181;L of medium I. 
		NOTE: Use a multichannel pipette to complete the half medium change. Conduct this step gently to ensure that no cell pellets are removed from the well. Aspirate the medium into a clean 10 cm Petri dish. If there are cell pellets inside, add them back to the 96-well plate.</li>
	</ol>
	</li>
	<li>Day 12- 18
	<ol>
		<li>Change the medium to medium II (Table 1) at day 12. Prepare medium II using 1% (v/v) reagent A by mixing the following: 10% fetal bovine serum (FBS), 0.1 mM NEAA, 1 mM pyruvate,100 U/mL penicillin, 100 &#181;g/mL streptomycin, 0.1 mM &#946;-mercaptoethanol, 100 nM SAG dihydrochloride and GMEM. Store it under cool and dark conditions.</li>
		<li>Harvest the cell pellets in a 15 mL conical tube from the 96-well plate and allow the pellets to settle naturally for 5 min at room temperature. 
		NOTE: Remove the medium and pellets gently under the surface to avoid bubbles.</li>
		<li>Remove the supernatant while taking care of the organoids. Transfer the cell aggregates to a 10 cm suspension dish containing 18 mL of prepared medium II with reagent A. 
		NOTE: Do not add the prepared medium II into the 10 cm dish in advance, as the reagent A should be at 4 &#176;C.</li>
		<li>Incubate at 37 &#176;C and 5% CO2 until day 18.</li>
	</ol>
	</li>
	<li>From day 18 onwards
	<ol>
		<li>Change the medium to medium III (Table 1). Prepare medium III under dark conditions by mixing the following: 10% FBS, 1xsupplement 1, 0.5 &#181;M retinoic acid (RA), 100 &#181;M taurine, 100 U/mL penicillin, 100 &#181;g/mL streptomycin and 1:1 mixture of Dulbecco&#39;s modified eagle medium (DMEM)/nutrient mixture F-12.</li>
		<li>On day 18, when a semitransparent optic vesicle is generated, cut the organoids using a microsurgical knife. 
		NOTE: Cleave the organoid, usually into four pieces, in a Petri dish with medium II. Each piece should grow into an intact optic cup in the following weeks.</li>
		<li>Aggregate all the pellets to the center of the dish. Harvest the cells into a 15 mL conical falcon tube and allow natural settling. Then gently remove the supernatant. 
		&#8203;NOTE: Due to their sizes, organoids can be aggregated at the center by rotating the Petri dish in one direction for 90&#176; on a horizontal plane a few times.</li>
		<li>Suspend and disperse the pellets in two 10 cm Petri dishes, with 18 mL of medium III per dish, and gently transfer the dishes to the incubator to avoid cell aggregation. Continue culturing in medium III at 37 &#176;C and 5% CO2 and change the medium weekly. The CRX expressed after day 45 and until day 120, we could detect the out-segment of the photoreceptor.</li>
	</ol>
	</li>
</ol>
2. Analyzing human ROs
<ol>
	<li>FACS analysis
	<ol>
		<li>Assemble three CRX-tdTomato and three H9 ES-derived organoids from the dishes by using the cut 1 mL tips. Wash the organoids with 1 mL of pre-warmed (room temperature) DPBS.</li>
		<li>Prepare the digestion buffer by mixing 0.25% trypsin-EDTA Solution with 0.05 mg/mL of reagent D.</li>
		<li>Dissociate the organoids into single cells by using the prepared digestion buffer for 8 min at 37 &#176;C. Then add the same volume of DPBS with 10% FBS and 0.05 mg/mL of reagent D to inactivate the reaction.</li>
		<li>Lightly suspend and scatter the cells and then filter using a 100 &#181;m cell strainer and use a Fluorescence-Activated Cell Sorting (FACS) system at 561 nm excitation laser line and 780/60 filter to analyze the CRX-tdTomato positive signals. 
		NOTE: CRX initially expresses at day 45 and increases with the maturation of organoids. Ten thousand cells are used for each test, for each timepoint, at least three repeats are completed.</li>
	</ol>
	</li>
	<li>Fluorescence intensity quantification of ROs
	<ol>
		<li>Prepare the viable organoids randomly for imaging. 
		NOTE: Set the parameters and use the same filters and parameters for all the fluorescence intensity monitors.</li>
		<li>Capture images and analyze the mean fluorescence intensity using suitable software (e.g., ImageJ).</li>
		<li>Import the images and then convert to 8-bit using Image | Type.</li>
		<li>Adjust the threshold by using the default parameters by Image | Adjust | Threshold.</li>
		<li>Determine the measured area and then evaluate the gray value by using Analyze | Measure. 
		NOTE: The mean values in the result panel are the mean fluorescence intensity of the measured area.</li>
	</ol>
	</li>
</ol>

<ol><li>Xie, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Chromatin+accessibility+analysis+reveals+regulatory+dynamics+of+developing+human+retina+and+hiPSC-derived+retinal+organoids%5BTitle%5D)+AND+%22Science+Advances%22%5BJournal%5D)">Chromatin accessibility analysis reveals regulatory dynamics of developing human retina and hiPSC-derived retinal organoids.</a> Science Advances. 6 (6), 5247(2020).</li>
<li>Lu, Y. F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Single-Cell+Analysis+of+Human+Retina+Identifies+Evolutionarily+Conserved+and+Species-Specific+Mechanisms+Controlling+Development%5BTitle%5D)+AND+%22Developmental+Cell%22%5BJournal%5D)">Single-Cell Analysis of Human Retina Identifies Evolutionarily Conserved and Species-Specific Mechanisms Controlling Development.</a> Developmental Cell. 53 (4), 473-491 (2020).</li>
<li>Cowan, C. S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Cell+Types+of+the+Human+Retina+and+Its+Organoids+at+Single-Cell+Resolution%5BTitle%5D)+AND+%22Cell%22%5BJournal%5D)">Cell Types of the Human Retina and Its Organoids at Single-Cell Resolution.</a> Cell. 182 (6), 1623-1640 (2020).</li>
<li>Jin, Z. B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Stemming+retinal+regeneration+with+pluripotent+stem+cells%5BTitle%5D)+AND+%22Progress+in+Retinal+and+Eye+Research%22%5BJournal%5D)">Stemming retinal regeneration with pluripotent stem cells.</a> Progress in Retinal and Eye Research. 69, 38-56 (2019).</li>
<li>Nakano, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Self-formation+of+optic+cups+and+storable+stratified+neural+retina+from+human+ESCs%5BTitle%5D)+AND+%22Cell+Stem+Cell%22%5BJournal%5D)">Self-formation of optic cups and storable stratified neural retina from human ESCs.</a> Cell Stem Cell. 10 (6), 771-785 (2012).</li>
<li>Pan, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((COCO+enhances+the+efficiency+of+photoreceptor+precursor+differentiation+in+early+human+embryonic+stem+cell-derived+retinal+organoids%5BTitle%5D)+AND+%22Stem+Cell+Research+and+Therapy%22%5BJournal%5D)">COCO enhances the efficiency of photoreceptor precursor differentiation in early human embryonic stem cell-derived retinal organoids.</a> Stem Cell Research and Therapy. 11 (1), 366(2020).</li>
<li>Zhou, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Differentiation+of+human+embryonic+stem+cells+into+cone+photoreceptors+through+simultaneous+inhibition+of+BMP%2C+TGFbeta+and+Wnt+signaling%5BTitle%5D)+AND+%22Development%22%5BJournal%5D)">Differentiation of human embryonic stem cells into cone photoreceptors through simultaneous inhibition of BMP, TGFbeta and Wnt signaling.</a> Development. 142 (19), 3294-3306 (2015).</li>
<li>Deng, W. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Gene+Correction+Reverses+Ciliopathy+and+Photoreceptor+Loss+in+iPSC-Derived+Retinal+Organoids+from+Retinitis+Pigmentosa+Patients%5BTitle%5D)+AND+%22Stem+Cell+Reports%22%5BJournal%5D)">Gene Correction Reverses Ciliopathy and Photoreceptor Loss in iPSC-Derived Retinal Organoids from Retinitis Pigmentosa Patients.</a> Stem Cell Reports. 10 (4), 1267-1281 (2018).</li>
<li>Gao, M. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Patient-Specific+Retinal+Organoids+Recapitulate+Disease+Features+of+Late-Onset+Retinitis+Pigmentosa%5BTitle%5D)+AND+%22Frontiers+in+Cell+and+Developmental+Biology%22%5BJournal%5D)">Patient-Specific Retinal Organoids Recapitulate Disease Features of Late-Onset Retinitis Pigmentosa.</a> Frontiers in Cell and Developmental Biology. 8, 128(2020).</li>
<li>Zhang, C. J., Ma, Y., Jin, Z. B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+road+to+restore+vision+with+photoreceptor+regeneration%5BTitle%5D)+AND+%22Experimental+Eye+Research%22%5BJournal%5D)">The road to restore vision with photoreceptor regeneration.</a> Experimental Eye Research. 202, 108283(2020).</li>
<li>Reichman, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((From+confluent+human+iPS+cells+to+self-forming+neural+retina+and+retinal+pigmented+epithelium%5BTitle%5D)+AND+%22Proceedings+of+the+National+Academy+of+Sciences+of+the+U.+S.+A%22%5BJournal%5D)">From confluent human iPS cells to self-forming neural retina and retinal pigmented epithelium.</a> Proceedings of the National Academy of Sciences of the U. S. A. 111 (23), 8518-8523 (2014).</li>
<li>Kuwahara, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Generation+of+a+ciliary+margin-like+stem+cell+niche+from+self-organizing+human+retinal+tissue%5BTitle%5D)+AND+%22Nature+Communications%22%5BJournal%5D)">Generation of a ciliary margin-like stem cell niche from self-organizing human retinal tissue.</a> Nature Communications. 6, 6286(2015).</li>
</ol>

Retinal organoid differentiation is a desirable method for the generation of ample functional retinal cells. The RO is a composite of different retinal cells, such as ganglion cells, bipolar cells, and photoreceptors, generated by pluripotent stems cells toward the neural retina4,5,8,9. Although confluent ROs could be harvested, it is time-consuming, which may require long culturing periods (up...

Pluripotent stem cells (PSCs) are characterized by their self-renewal and ability to differentiate into all kinds of somatic cells. Thus, organoids derived from PSCs have become an important resource in regenerative medicine research. Retinal degeneration is characterized by the loss of photoreceptors (rods and cones) and retinal pigment epithelium. Retinal cell replacement could be an encouraging treatment for this disease. However, it is not feasible to obtain human retinas for disease research and therapy. Therefore, retinal organoids (ROs) derived from PSCs, which effectively and successfully recapitulate multi-layered native retinal cells, are beneficial for basic and translational research1,2,3. Our research focuses on RO differentiation to provide sufficient and quality cells for studying retinal degeneration4.
Methods for differentiating ROs are continuously emerging, with three-dimensional (3D) suspension differentiation pioneered by the Sasai laboratory in 20125. We introduced the CRX-tdTomato tag in the human embryonic stem cells (hESCs) to specifically track the photoreceptor precursor cells and modified the method with the addition of COCO, a multifunctional antagonist of the Wnt, TGF-&#946;, and BMP pathways6. COCO has been shown to efficiently improve the differentiation efficiency of photoreceptor precursors and cones6,7.
Altogether, by modifying the classical differentiation method, we have developed an accessible protocol to harvest abundant photoreceptor precursors and cones from human ROs for analyzing the retinal disease associated with the photoreceptors through laboratory investigations and for further clinical application/transplantation.

<table><tbody><tr><td>2-mercaptoethanol</td><td>Life Technologies</td><td>21985-023</td><td></td></tr><tr><td>COCO</td><td>R&amp;amp;D Systems</td><td>3047-CC-050</td><td>DAN Domain family of BMP antagonists</td></tr><tr><td>DMEM/F-12</td><td>Gibco</td><td>10565-042</td><td></td></tr><tr><td>DMSO</td><td>Sigma</td><td>D2650</td><td></td></tr><tr><td>DPBS</td><td>Gibco</td><td>C141905005BT</td><td></td></tr><tr><td>EDTA</td><td>Thermo</td><td>15575020</td><td></td></tr><tr><td>Fetal Bovine Serum (FBS), Qualified for Human Embryonic Stem Cells</td><td>Biological Industry</td><td>04-002-1A</td><td></td></tr><tr><td>GMEM</td><td>Gibco</td><td>11710-035</td><td></td></tr><tr><td>KnockOut Serum Replacement-Multi-Species</td><td>Gibco</td><td>A3181502</td><td></td></tr><tr><td>MEM Non-essential Amino Acid Solution (100X)</td><td>sigma</td><td>M7145</td><td></td></tr><tr><td>Pen Strep</td><td>Gibco</td><td>15140-122</td><td></td></tr><tr><td>Primesurface 96 V-plate</td><td>Sbio</td><td>MS9096SZ</td><td>Cell aggregation in 1.2.7</td></tr><tr><td>Pyruvate</td><td>Sigma</td><td>S8636</td><td></td></tr><tr><td>Reagent A</td><td>BD</td><td>356231</td><td>Matrigel in 1.1.1</td></tr><tr><td>Reagent B</td><td>StemCell</td><td>5990</td><td>mTeSR- E8 , PSCs basal medium in 1.1.2</td></tr><tr><td>Reagent C</td><td>Gibco</td><td>12563-011</td><td>TrypLE Express in 1.2</td></tr><tr><td>Reagent D</td><td>Roche</td><td>11284932001</td><td>DNase I , in 1.2</td></tr><tr><td>Retinoic acid</td><td>Sigma</td><td>R2625-100MG</td><td></td></tr><tr><td>SAG</td><td>Enzo Life Science</td><td>ALX-270-426-M001</td><td></td></tr><tr><td>Supplement 1</td><td>Life Technologies</td><td>17502-048</td><td>N-2 Supplement (100X), Liquid, supplemet in medum III</td></tr><tr><td>Taurine</td><td>Sigma</td><td>T-8691-25G</td><td></td></tr><tr><td>Trypsin-EDTA (0.25%), phenol red</td><td>Gibco</td><td>25200056</td><td>organoids dissociation in 2.1.3</td></tr><tr><td>Wnt Antagonist I, IWR-1-endo - Calbiochem</td><td>Sigma</td><td>681669</td><td>Wnt inhibitor</td></tr><tr><td>Y-27632 2HCl</td><td>Selleck</td><td>S1049</td><td></td></tr></tbody></table>

directed induction of retinal organoids from human pluripotent stem cells

Directed Induction of Retinal Organoids from Human Pluripotent Stem Cells

Retinal cell transplantation is a promising therapeutic approach, which could restore the retinal architecture and stabilize or even improve the visual capabilities to the degenerated retina. Nevertheless, progress in cell replacement therapy presently faces the challenges of requiring an off-the-shelf source of high quality and standardized human retinas. Therefore, an easy and stable protocol is needed for the experiments. Here, we develop an optimized protocol, based on a self-organizing method with the use of exogenous molecules and reagent A as well as manual excision to generate the three-dimensional human retina organoids (RO). The human Pluripotent Stem Cells (PSCs)-derived RO expresses specific markers for photoreceptors. With the addition of COCO, a multifunctional antagonist, the differentiation efficiency of photoreceptor precursors and cones is significantly increased. The efficient use of this system, which has the benefits of cell lines and primary cells, and without the sourcing issues associated with the latter, could produce confluent retinal cells, especially photoreceptors. Thus, the differentiation of PSCs to RO provides an optimal and biorelevant platform for disease modelling, drug screening and cell transplantation.

The schematic illustration depicts the differentiation protocol to improve precursor cells with COCO (Figure 1). From PSC to ROs, numerous details could cause result variations. It is recommended to record every step and even the catalog number and lot number of every medium to track the entire procedure.
Herein, we provide bright field images for days 6, 12, 18, and 45 (Figure 2). On day 6, the organoids are usually around 600 µm in ...

Using a self-organizing method, we develop a protocol with the addition of COCO that could significantly increase the generation of photoreceptors.

Retinal cell transplantation is a promising therapeutic approach, which could restore the retinal architecture and stabilize or even improve the visual ...

directed-induction-retinal-organoids-from-human-pluripotent-stem

Research

JoVE Journal

Medicine

Stem cell-derived retinal pigment epithelium  (RPE) cells may be used for multiple applications including cell-based therapies for retinal degeneration, disease modeling, and drug studies. Here we present a simple protocol for reproducibly deriving RPE from stem cells.

Efficient Derivation of Retinal Pigment Epithelium Cells from Stem Cells

This protocol describes how to produce retinal pigment epithelial cells (RPE) from pluripotent stem cells. The method uses a combination of growth factors and small molecules to direct the differentiation of stem cells into immature RPE in fourteen days and mature, functional RPE after three months.

Rapid, Directed Differentiation of Retinal Pigment Epithelial Cells from Human Embryonic or Induced Pluripotent Stem Cells

The production of specialized retinal cells from pluripotent stem cells is a turning point in the development of stem cell-based therapy for retinal diseases. The present paper describes a simple method for an efficient generation of retinal organoids and retinal pigmented epithelium for basic, translational, and clinical research.

Defined Xeno-free and Feeder-free Culture Conditions for the Generation of Human iPSC-derived Retinal Cell Models

Here we describe an optimized retinal organoid induction system, which is suitable for various human pluripotent stem cell lines to generate retinal tissues with high reproducibility and efficiency.

Retinal Organoid Induction System for Derivation of 3D Retinal Tissues from Human Pluripotent Stem Cells

This protocol describes an efficient method of differentiating hiPSCs into eye field clusters and generating neuro-retinal organoids using simplified culture conditions involving both adherent and suspension culture systems. Other ocular cell types, such as the RPE and corneal epithelium, can also be isolated from mature eye fields in retinal cultures.

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells

The present protocol describes an optimized 3D neural retina induction system that reduces the adhesion and fusion of retinal organoids with high repeatability and efficiency.

Generating Neural Retina from Human Pluripotent Stem Cells

This protocol presents a method for generating vascular organoids using human pluripotent stem cells.

Vascular Organoid Generation from Human-Induced Pluripotent Stem Cells

This protocol combines optical clearing and immunolabeling for full-volume confocal imaging of whole-mount retinal organoids. It preserves 3D structure, enabling detailed visualization of key neuronal pathways, improving the study of retinal maturation, spatial organization, and its potential applications in disease modeling and personalized medicine.

Whole-mount Retinal Organoid Visualization with Cellular Resolution

The method described isolation and characterization of human Dental Pulp Stem Cells (hDPSCs) by using either enzymatic dissociation of pulp (DPSC-ED) or direct outgrowth of stem cells from pulp tissue explants (DPSC-OG). Then followed by in vitro comparative differentiation of both types of hDPSCs into odontoblasts.

Isolation, Characterization and Comparative Differentiation of Human Dental Pulp Stem Cells Derived from Permanent Teeth by Using Two Different Methods

The isolation of cancer stem cells (CSCs) directly from human tissues is requisite for their biological characterization. This manuscript describes a methodology for the isolation of prostate CSCs from human tissues, while also providing tips on troubleshooting difficult steps.

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

Learn to generate retinal organoids from human pluripotent stem cells using feeder-free culture and manual selection. This optimized protocol enhances photoreceptor precursor yield for disease modeling and transplantation research.

Directed Induction of Retinal Organoids from Human Pluripotent Stem Cells

Explore More Videos